Medical guideline

首页肿瘤学指南检索结果

检索结果

按发表年份

共搜索到22条与Therapy.有关的结果

Molecular Pathology of Urogenital Tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference

2021年发布于 Pathologe 42卷第3期 所属人体系统：泌尿、生殖 | 泌尿生殖肿瘤

2019 International Society of Urological Pathology (ISUP) Consensus Conference

Bladder Cancer Kidney Cancer Molecular Biomarker Prostate Cancer Targeted Therapy.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：其他 | 腹膜肿瘤

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 输卵管癌

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
Clinical Practice Guidelines for the Management of Liver Metastases from Extrahepatic Primary Cancers 2021

2021年发布于 J Hepatobiliary Pancreat Sci . 28卷第1期 所属人体系统：消化 | 肝肿瘤

Japanese Society of Hepato-Biliary-Pancreatic Surgery

Ablation Therapy Disappearing Liver Metastases Hepatectomy Metastatic Liver Tumors Systemic Therapy.
指南简介 原文链接
Clinical Practice Guideline for Stage Ⅳ Primary Lung Cancer in China(2021 Version)

2021年发布于 Zhonghua Zhong Liu Za Zhi 43卷第1期 所属人体系统：呼吸 | 肺癌

Chinese Association for Clinical Oncologists and Medical Oncology Branch of Chinese International Exchange Promotion Association for Medical and Healthcare

Diagnosis Lung Neoplasms Standard Therapy.
指南简介 原文链接
Clinical Practice Guideline for Brain Metastases of Lung Cancer in China (2021 Version)

2021年发布于 Zhonghua Zhong Liu Za Zhi 43卷第3期 所属人体系统：呼吸 | 肺癌

Chinese Association for Clinical Oncologists Medical Oncology Branch of Chinese International Exchange and Promotion Association for Medical and Healthcare

Brain Metastases Lung Neoplasms Standard Therapy.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
Management of Metabolic Adverse Events of Targeted Therapies and Immune Checkpoint Inhibitors in Cancer Patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) Multidisciplinary

2020年发布于 Critical Reviews in Oncology/Hematology 154卷第期 所属人体系统：其他 | 治疗方案

Associazione Italiana Oncologia Medica Associazione Medici Diabetologi Società Italiana Farmacologia

Diabetes Dyslipidemia Hypercholesterolemia Hyperglycemia Hypertriglyceridemia Immunotherapy Metabolic Effect Targeted Therapy.
指南简介 原文链接
Guideline for Diagnosis and Management of Hairy Cell Leukaemia (HCL) and Hairy Cell Variant (HCL-V)

2020年发布于 Br J Haematol 191卷第5期 所属人体系统：循环 | 白血病

British Society for Haematology Guidelines Committee Haemato-Oncology Taskforce the BSH Guidelines Committee and the Haemato-Oncology Sounding Board of BSH

BRAF V600E Mutation Differential Diagnosis Hairy Cell Variant Hairy Cell Leukaemia Therapy.
指南简介 原文链接
Consensus Recommendations for Optimizing Biomarker Testing to Identify and Treat Advanced EGFR-Mutated Non-Small-Cell Lung Cancer

2020年发布于 Current oncology (Toronto, Ont.) 27卷第6期 所属人体系统：呼吸 | 肺癌

无

Biomarker Testing EGFR T790M Comprehensive Biomarker Testing Egfr Epidermal Growth Factor Receptor Non-small-cell Lung Cancer Nsclc Targeted Therapy.
指南简介 原文链接
Clinical Practice Guideline for Stage Ⅳ Primary Lung Cancer in China(2020 Version)

2020年发布于 Zhonghua Zhong Liu Za Zhi 42卷第1期 所属人体系统：呼吸 | 肺癌

Chinese Association for Clinical Oncologists

Diagnosis Lung Neoplasms Therapy.
指南简介 原文链接
Chinese Medical Association Guidelines for Clinical Diagnosis and Treatment of Lung Cancer (2019 Edition)

2020年发布于 Zhonghua Zhong Liu Za Zhi 42卷第4期 所属人体系统：呼吸 | 肺癌

Chinese Medical Association Oncology Society of Chinese Medical Association Chinese Medical Association Publishing House

Diagnosis Guidelines Lung Neoplasms Therapy.
指南简介 原文链接
Chinese Expert Consensus on Stereotactic Body Radiation Therapy for Early Stage Non-small Cell Lung Cancer (2019 Edition)

2020年发布于 Zhonghua Zhong Liu Za Zhi 42卷第7期 所属人体系统：呼吸 | 肺癌

Radiation Oncology Branch of Chinese Medical Association Radiation Therapy Committee of China Anti-Cancer Association Radiation Oncologist Branch of Chinese Medical Doctor Association

Carcinoma Non-small-cell Lung Expert Consensus Stereotactic Body Radiation Therapy.
指南简介 原文链接
Chinese Expert Consensus on Anlotinib Hydrochloride for Advanced Lung Cancer (2020 Edition)

2020年发布于 Zhonghua Zhong Liu Za Zhi 42卷第10期 所属人体系统：呼吸 | 肺癌

Chinese Association for Clinical Oncologists Expert Committee of Vascular Targeted Therapy of Chinese Society of Clinical Oncology Cancer Targeted Therapy Professional Committee of China Anti-Cancer Association

Anlotinib Hydrochloride Consensus Lung Neoplasms Therapy.
指南简介 原文链接
Biochemical Recurrence in Prostate Cancer: the European Association of Urology Prostate Cancer Guidelines Panel Recommendations

2020年发布于 European Urology Focus 6卷第2期 所属人体系统：生殖 | 前列腺肿瘤

European Association of Urology

Biochemical Recurrence European Association of Urology Gleason Score Guidelines PSA Kinetics Prognostic Factors Prostate Cancer Radical Prostatectomy Radiotherapy.
指南简介 原文链接
Systemic Adjuvant Therapy for Adult Patients at High Risk for Recurrent Cutaneous Or Mucosal Melanoma: an Ontario Health (cancer Care Ontario) Clinical Practice Guideline

2020年发布于 Current Oncology 27卷第1期 所属人体系统：其他 | 黑色素瘤

Evidence-Based Care (pebc) at Ontario Health (Cancer Care Ontario) Melanoma Disease Site Group

Melanoma Adjuvant Therapy Immune Checkpoint Inhibitors Interferon Practice Guidelines Targeted Therapy.
指南简介 原文链接
Treatment Guidelines of Metastatic Colorectal Cancer in Older Patients from the French Society of Geriatric Oncology (SoFOG)

2020年发布于 Digestive and Liver Disease 52卷第5期 所属人体系统：消化 | 结直肠肿瘤

French Society of Geriatric Oncology

Chemotherapy Colorectal Cancer Metastasis Older Patient Targeted Therapy.
指南简介 原文链接
Treatment of Invasive Fungal Diseases in Cancer Patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

2020年发布于 Mycoses 63卷第7期 所属人体系统：其他 | 症状管理

Infectious Diseases Working Party of the German Society of Hematology and Oncology

Antifungal Agents Aspergillosis Candidosis- Mucormycosis Haematologic Malignancies-cancer-IFD Invasive Fungal Disease Mycoses Therapy.
指南简介 原文链接
Breast Cancer Management Guidelines During COVID-19 Pandemic

2020年发布于 Indian J Surg 卷第期 所属人体系统：生殖 | 乳腺肿瘤

无

Breast Cancer Breast Surgery COVID-19 Chemotherapy Radiotherapy.
指南简介 原文链接
Diagnosis and Treatment of Basal Cell Carcinoma: European Consensus-based Interdisciplinary Guidelines

2019年发布于 Eur J Cancer 118卷第_期 所属人体系统：其他 | 皮肤肿瘤

European Dermatology Forum European Association of Dermato-Oncology European Organization for Research and Treatment of Cancer

Basal Cell Carcinoma Classification Destructive Therapy Guidelines Hedgehog Inhibitors Immunotherapy Photodynamic Therapy Radiotherapy Surgical Therapy Topical Therapy.
指南简介 原文链接

人体系统

共搜索到22条 与Therapy.有关的结果

2021年 发布于 Pathologe 42卷 第3期 所属人体系统： 泌尿、 生殖 | 泌尿生殖肿瘤

2019 International Society of Urological Pathology (ISUP) Consensus Conference

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 其他 | 腹膜肿瘤

Ontario Health (Cancer Care Ontario)

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 输卵管癌

Ontario Health (Cancer Care Ontario)

2021年 发布于 J Hepatobiliary Pancreat Sci . 28卷 第1期 所属人体系统： 消化 | 肝肿瘤

Japanese Society of Hepato-Biliary-Pancreatic Surgery

2021年 发布于 Zhonghua Zhong Liu Za Zhi 43卷 第1期 所属人体系统： 呼吸 | 肺癌

Chinese Association for Clinical Oncologists and Medical Oncology Branch of Chinese International Exchange Promotion Association for Medical and Healthcare

2021年 发布于 Zhonghua Zhong Liu Za Zhi 43卷 第3期 所属人体系统： 呼吸 | 肺癌

Chinese Association for Clinical Oncologists Medical Oncology Branch of Chinese International Exchange and Promotion Association for Medical and Healthcare

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

Ontario Health (Cancer Care Ontario)

2020年 发布于 Critical Reviews in Oncology/Hematology 154卷 第期 所属人体系统： 其他 | 治疗方案

Associazione Italiana Oncologia Medica Associazione Medici Diabetologi Società Italiana Farmacologia

2020年 发布于 Br J Haematol 191卷 第5期 所属人体系统： 循环 | 白血病

British Society for Haematology Guidelines Committee Haemato-Oncology Taskforce the BSH Guidelines Committee and the Haemato-Oncology Sounding Board of BSH

2020年 发布于 Current oncology (Toronto, Ont.) 27卷 第6期 所属人体系统： 呼吸 | 肺癌

无

2020年 发布于 Zhonghua Zhong Liu Za Zhi 42卷 第1期 所属人体系统： 呼吸 | 肺癌

Chinese Association for Clinical Oncologists

2020年 发布于 Zhonghua Zhong Liu Za Zhi 42卷 第4期 所属人体系统： 呼吸 | 肺癌

Chinese Medical Association Oncology Society of Chinese Medical Association Chinese Medical Association Publishing House

2020年 发布于 Zhonghua Zhong Liu Za Zhi 42卷 第7期 所属人体系统： 呼吸 | 肺癌

Radiation Oncology Branch of Chinese Medical Association Radiation Therapy Committee of China Anti-Cancer Association Radiation Oncologist Branch of Chinese Medical Doctor Association

2020年 发布于 Zhonghua Zhong Liu Za Zhi 42卷 第10期 所属人体系统： 呼吸 | 肺癌

Chinese Association for Clinical Oncologists Expert Committee of Vascular Targeted Therapy of Chinese Society of Clinical Oncology Cancer Targeted Therapy Professional Committee of China Anti-Cancer Association

2020年 发布于 European Urology Focus 6卷 第2期 所属人体系统： 生殖 | 前列腺肿瘤

European Association of Urology

2020年 发布于 Current Oncology 27卷 第1期 所属人体系统： 其他 | 黑色素瘤

Evidence-Based Care (pebc) at Ontario Health (Cancer Care Ontario) Melanoma Disease Site Group

2020年 发布于 Digestive and Liver Disease 52卷 第5期 所属人体系统： 消化 | 结直肠肿瘤

French Society of Geriatric Oncology

2020年 发布于 Mycoses 63卷 第7期 所属人体系统： 其他 | 症状管理

Infectious Diseases Working Party of the German Society of Hematology and Oncology

2020年 发布于 Indian J Surg 卷 第期 所属人体系统： 生殖 | 乳腺肿瘤

无

2019年 发布于 Eur J Cancer 118卷 第_期 所属人体系统： 其他 | 皮肤肿瘤

European Dermatology Forum European Association of Dermato-Oncology European Organization for Research and Treatment of Cancer

共搜索到22条与Therapy.有关的结果

2021年发布于 Pathologe 42卷第3期 所属人体系统：泌尿、生殖 | 泌尿生殖肿瘤

2021年发布于 Current Oncology 28卷第2期 所属人体系统：其他 | 腹膜肿瘤

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 输卵管癌

2021年发布于 J Hepatobiliary Pancreat Sci . 28卷第1期 所属人体系统：消化 | 肝肿瘤

2021年发布于 Zhonghua Zhong Liu Za Zhi 43卷第1期 所属人体系统：呼吸 | 肺癌

2021年发布于 Zhonghua Zhong Liu Za Zhi 43卷第3期 所属人体系统：呼吸 | 肺癌

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2020年发布于 Critical Reviews in Oncology/Hematology 154卷第期 所属人体系统：其他 | 治疗方案

2020年发布于 Br J Haematol 191卷第5期 所属人体系统：循环 | 白血病

2020年发布于 Current oncology (Toronto, Ont.) 27卷第6期 所属人体系统：呼吸 | 肺癌

2020年发布于 Zhonghua Zhong Liu Za Zhi 42卷第1期 所属人体系统：呼吸 | 肺癌

2020年发布于 Zhonghua Zhong Liu Za Zhi 42卷第4期 所属人体系统：呼吸 | 肺癌

2020年发布于 Zhonghua Zhong Liu Za Zhi 42卷第7期 所属人体系统：呼吸 | 肺癌

2020年发布于 Zhonghua Zhong Liu Za Zhi 42卷第10期 所属人体系统：呼吸 | 肺癌

2020年发布于 European Urology Focus 6卷第2期 所属人体系统：生殖 | 前列腺肿瘤

2020年发布于 Current Oncology 27卷第1期 所属人体系统：其他 | 黑色素瘤

2020年发布于 Digestive and Liver Disease 52卷第5期 所属人体系统：消化 | 结直肠肿瘤

2020年发布于 Mycoses 63卷第7期 所属人体系统：其他 | 症状管理

2020年发布于 Indian J Surg 卷第期 所属人体系统：生殖 | 乳腺肿瘤

2019年发布于 Eur J Cancer 118卷第_期 所属人体系统：其他 | 皮肤肿瘤